Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study
Multiple lines of evidence suggest that a deficiency of Fragile X Mental Retardation Protein (FMRP) mediates dysfunction of the metabotropic glutamate receptor subtype 5 (mGluR<sub>5</sub>) in the pathogenesis of fragile X syndrome (FXS), the most commonly known single-gene cause of inhe...
Main Authors: | James Robert Brašić, Jack Alexander Goodman, Ayon Nandi, David S. Russell, Danna Jennings, Olivier Barret, Samuel D. Martin, Keith Slifer, Thomas Sedlak, Anil Kumar Mathur, John P. Seibyl, Elizabeth M. Berry-Kravis, Dean F. Wong, Dejan B. Budimirovic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/12/3/314 |
Similar Items
-
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome
by: James R. Brašić, et al.
Published: (2020-11-01) -
Arbaclofen in fragile X syndrome: results of phase 3 trials
by: Elizabeth Berry-Kravis, et al.
Published: (2017-06-01) -
Molecular Biomarkers in Fragile X Syndrome
by: Marwa Zafarullah, et al.
Published: (2019-04-01) -
Fragile X syndrome - insight into what we know and prospects
by: Adam Strzoda, et al.
Published: (2023-04-01) -
Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the <i>Fmr1</i>-KO Mouse Model of Fragile X Syndrome
by: Marika Premoli, et al.
Published: (2023-07-01)